Ionis Pharmaceuticals: Q2 Earnings Snapshot

August 9, 2022 GMT

CARLSBAD, Calif. (AP) _ Ionis Pharmaceuticals Inc. (IONS) on Tuesday reported a loss of $105 million in its second quarter.

The Carlsbad, California-based company said it had a loss of 74 cents per share.

The results missed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 61 cents per share.

The drug discovery and development company posted revenue of $134 million in the period, which also did not meet Street forecasts. Eight analysts surveyed by Zacks expected $147.7 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on IONS at